S24 A phase i feasibility study in establishing the role of ultrasound-guided pleural biopsies in pleural infection (the audio study)

BackgroundPleural infection is a common complication of pneumonia associated with high mortality and poor clinical outcome. Treatment of pleural infection relies on the use of broad-spectrum antibiotics, since reliable pathogen identification occurs infrequently. We performed a feasibility intervent...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Thorax 2017-12, Vol.72 (Suppl 3), p.A17
Hauptverfasser: Psallidas, I, Kanellakis, N, Bhatnagar, R, Ravindran, R, Yousuf, A, Edey, AJ, Mercer, RM, Corcoran, JP, Hallifax, RJ, Shetty, P, Dong, T, Piotrowska, HEG, Clelland, C, Maskell, NA, Rahman, NM
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:BackgroundPleural infection is a common complication of pneumonia associated with high mortality and poor clinical outcome. Treatment of pleural infection relies on the use of broad-spectrum antibiotics, since reliable pathogen identification occurs infrequently. We performed a feasibility interventional clinical trial assessing the safety and significance of ultrasound (US)-guided pleural biopsy culture to increase the microbiological yield.Methods20 patients with clinically established pleural infection were recruited. Participants underwent a detailed US scan and US-guided pleural biopsies before chest drain insertion, alongside standard clinical management. Pleural biopsies and routine clinical samples (pleural fluid and blood) were submitted for microbiological analysis. In an exploratory sub-study, the 16S rRNA technique was applied on pleural biopsy samples, to investigate its’ utility on increasing speed and accuracy versus standard microbiological diagnosis. This trials is registered with ClinicalTrials.gov, number NCT02608814FindingsUS-guided were safe with no adverse events observed in this study. Pleural biopsies increased microbiological yield by 30% in addition to pleural fluid and blood samples (combined diagnostic sensitivity 55%). US characteristics at baseline were not statistically associated with survival, fluid volume drainage, radiological improvement or need for surgery. The 16S rRNA technique was successfully applied to pleural biopsy samples, demonstrating high sensitivity (93%) and specificity (89·5%).ConclusionOur findings demonstrate safety of conducting US guided biopsies in patients with pleural infection and a substantial increase in microbiological diagnosis. qPCR primer assessment of pleural fluid and biopsy appears to have excellent sensitivity and specificity.FundingOxfordshire Health Services Research CommitteeAbstract 24 Figure 1(A)% increase on positive culture samples in patients with pleural infection, (B) Results of pleural biopsy culture, and (C) Gram stain of acute inflammatory exudate in a pleural biopsy showing small colonies of Gram positive cocci.
ISSN:0040-6376
1468-3296
DOI:10.1136/thoraxjnl-2017-210983.30